The medical community has experienced a significant advancement in diabetes management with the arrival of copyright. This transformative medication, designated as a glucagon-like peptide-1 (GLP-1) receptor agonist, provides a novel approach to controlling blood sugar levels in individuals with type 2 diabetes. copyright works by mimicking the acti